Growth Metrics

Oculis Holding AG (OCS) Other Non-Current Liabilities (2023 - 2026)

Quarterly Other Non-Current Liabilities rose 57.89% to $26.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $26.2 million through Mar 2026, up 57.89% year-over-year, with the annual reading at $18.1 million for FY2025, 20.06% down from the prior year.

Oculis Holding AG's Other Non-Current Liabilities history spans 4 years, with the latest figure at $26.2 million for Q1 2026.

  • Other Non-Current Liabilities came in at $26.2 million for Q1 2026, up from $18.1 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $26.2 million in Q1 2026 to a low of $4.8 million in Q2 2023.
  • The 4-year median for Other Non-Current Liabilities is $12.4 million (2025), against an average of $13.5 million.
  • Year-over-year, Other Non-Current Liabilities surged 274.31% in 2024 and then decreased 20.06% in 2025.
  • Oculis Holding AG's Other Non-Current Liabilities stood at $6.1 million in 2023, then soared by 274.31% to $22.7 million in 2024, then decreased by 20.06% to $18.1 million in 2025, then skyrocketed by 44.81% to $26.2 million in 2026.
  • Per Business Quant, the three most recent readings for OCS's Other Non-Current Liabilities are $26.2 million (Q1 2026), $18.1 million (Q4 2025), and $15.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Oculis Holding AG 24.51 Bn 24.21 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 26.23 Mn
Dec 31, 2025 18.11 Mn
Sep 30, 2025 15.18 Mn
Jun 30, 2025 18.25 Mn
Mar 31, 2025 16.61 Mn
Dec 31, 2024 22.66 Mn
Sep 30, 2024 9.01 Mn
Jun 30, 2024 8.14 Mn
Mar 31, 2024 9.67 Mn
Dec 31, 2023 6.05 Mn
Sep 30, 2023 7.45 Mn
Jun 30, 2023 4.78 Mn